Tesla
TSLA
Alphabet-C
GOOG
Alphabet-A
GOOGL
4
Meta Platforms
META
5
Micron Technology
MU
US Stock MarketDetailed Quotes
BLUE bluebird bio
- 5.100
- +0.220+4.51%
Trading Apr 1 12:30 ET
49.93MMarket Cap-0.21P/E (TTM)
5.290High4.818Low418.31KVolume4.860Open4.880Pre Close2.12MTurnover4.30%Turnover RatioLossP/E (Static)9.79MShares28.60052wk High-1.58P/B49.59MFloat Cap3.56052wk Low--Dividend TTM9.72MShs Float3057.654Historical High--Div YieldTTM9.67%Amplitude3.560Historical Low5.057Avg Price1Lot Size
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call
bluebird bio Stock Forum
$bluebird bio (BLUE.US)$
Strong buyer 🚀🚀🤑🤑
🚀😉
good earning recently with a little bump 👀
SOMERVILLE, Mass.—(BUSINESS WIRE)—March 28, 2025— bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird”) today confirmed it has received an unsolicited non-binding written proposal (the “Ayrmid Proposal”) from Ayrmid Ltd (“Ayrmid”) to acquire bluebird for an upfront cash payment of $4.50 per share and a one-time contingent value right...
Bluebird Gets New M&A Bid, Seeking To Top Private Equity Offer' - Endpoints News
bluebird bio has entered into a definitive agreement to be acquired by Carlyle and SK Capital in a deal valuing the company at up to $9.84 per share. Shareholders will receive $3.00 per share in cash plus a contingent value right of $6.84 per share, payable if the company achieves $600 million in net sales within a specified period ending December 31, 2027.
The transaction comes after bluebird's comprehensive strategic review involving over 70 potential investors, ...
No comment yet